Discovery of a Dual‐Target Inhibitor of CDK7 and HDAC1 That Induces Apoptosis and Inhibits Migration in Colorectal Cancer**
ChemMedChem · 2023-12 · 18 (23)
DOI: 10.1002/cmdc.202300281 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 25.10.2023. Verfasst von Yao Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University,…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Colorectal Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aberrant expression or dysfunction of cyclin‐dependent kinase 7(CDK7) and histone deacetylase 1 (HDAC1) are associated with the occurrence and progression of various cancers. In this study, we developed a series of dual‐target inhibitors by designing and synthesizing compounds that incorporate the pharmacophores of THZ2 and SAHA. The most potent dual‐target inhibitor displayed robust inhibitory activity against several types of cancer cells and demonstrated promising inhibitory effects on both CDK7 and HDAC1. After further mechanistic studies, it was discovered that this inhibitor effectively arrested HCT‐116 cells at the G2 phase and induced apoptosis. Additionally, it also significantly hindered the migration of HCT‐116 cells and exhibited notable anti‐tumor effects. These findings offer strong support for the development of dual‐target inhibitors of CDK7 and HDAC1 and provide a promising avenue for future cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu, 610031, China.
ORCID-Profile: Lan Zhang
Förderung
- Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Chen, Y., Zhang, S., Li, Z., Yin, B., Liu, Y., & Zhang, L. (2023). Discovery of a Dual‐Target Inhibitor of CDK7 and HDAC1 That Induces Apoptosis and Inhibits Migration in Colorectal Cancer**. ChemMedChem, 18(23). https://doi.org/10.1002/cmdc.202300281
Vancouver
Chen Y, Zhang S, Li Z, Yin B, Liu Y, Zhang L. Discovery of a Dual‐Target Inhibitor of CDK7 and HDAC1 That Induces Apoptosis and Inhibits Migration in Colorectal Cancer**. ChemMedChem. 2023;18(23). doi:10.1002/cmdc.202300281
BibTeX
@article{Chen2023,
author = {Chen, Yao and Zhang, Shuangqian and Li, Zhijia and Yin, Bo and Liu, Yi and Zhang, Lan},
title = {Discovery of a Dual‐Target Inhibitor of CDK7 and HDAC1 That Induces Apoptosis and Inhibits Migration in Colorectal Cancer**},
journal = {ChemMedChem},
year = {2023},
volume = {18},
number = {23},
doi = {10.1002/cmdc.202300281}
}
EUVIMED